Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

AI Tool Predicts Bladder Cancer from Electronic Health Records

By HospiMedica International staff writers
Posted on 26 Aug 2026

Bladder cancer causes substantial mortality and is often detected late because early symptoms can resemble benign urologic conditions. More...

Reliance on visible hematuria and confirmatory cystoscopy may delay diagnosis while exposing patients to invasive procedures. Health systems therefore need noninvasive risk tools that can identify earlier warning signs within routine care. Researchers have now developed an artificial intelligence system that predicts bladder cancer risk years before formal diagnosis.

Developed at the University of Plymouth, the PRECISE-AGZ model analyzes electronic health records to identify subtle patterns that emerge before a bladder cancer diagnosis. The system examines routine clinical data, including symptoms, risk factors, and health care activity, allowing it to move beyond referral pathways based primarily on individual symptoms. Current pathways often emphasize visible hematuria, which can also arise from benign conditions and still requires cystoscopy for diagnostic confirmation.

The study analyzed nearly 70,000 patient records collected between 1995 and 2020. Using a purpose-built model, investigators evaluated 48,261 potential indicators spanning patient behaviors, comorbidities, medication histories, and other routinely recorded information. From this large set of variables, the algorithm identified 38 key features that were most strongly associated with bladder cancer risk.

PRECISE-AGZ detected bladder cancer in 85% of patients who had the disease and correctly identified cancer-free individuals with 91% accuracy. The model demonstrated effective detection up to 12 months before diagnosis, with some predictive signals appearing as early as five years beforehand, and it outperformed current National Health Service referral guidelines. 

The tool classified patients into low-risk, gray-zone, and high-risk groups, corresponding to probabilities below 7%, between 7% and 55%, and above 55%, respectively. This stratification could help prioritize patients for further evaluation, while those in the gray zone could potentially undergo continued monitoring before invasive testing, reducing unnecessary cystoscopies.

The model confirmed established associations such as smoking and hematuria while also identifying patterns that are less apparent through conventional screening approaches. Patients with Parkinson’s disease or dementia showed a lower observed risk, while long-term tamoxifen use was associated with higher risk, although these findings do not establish prevention or causation. 

The predictive significance of hematuria also changed when considered alongside other clinical indicators; for example, hematuria combined with benign prostate enlargement in men was associated with lower risk. These findings illustrate how the model integrates multiple factors rather than relying on individual warning signs in isolation.

The authors emphasize that further validation across different health care systems will be needed because all study data were drawn from the SAIL database in Wales. The findings, published in IEEE Transactions on Biomedical Engineering, suggest that incorporating AI-based risk assessment into routine clinical data could help identify bladder cancer earlier, improve referral prioritization, and reduce unnecessary invasive procedures.

“This work represents a paradigm shift toward precision screening for bladder cancer. By harnessing the power of interpretable machine learning and comprehensive health records, we’re moving closer to detecting this disease at its earliest, most treatable stages,” said Professor Shang-Ming Zhou at the University of Plymouth’s Center for Health Technology.

“It’s important to emphasize that further validation across different health care systems is essential before anything is rolled out more widely—for example, all of the data analyzed came from the SAIL database in Wales, so we’d want to investigate other data sets, too. But it’s a very exciting early study. Additional studies would also be needed to confirm the causal relationships suggested by the model’s predictions,” added Prof. Zhou.

Related Links
University of Plymouth’s Center for Health Technology


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Wound Irrigation Solution
Prontosan®
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.